Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10368	Companies
216016	Keywords
145738	Articles
114389	Press releases

Home
Companies
Biophytis

BRIEF

published on 06/20/2024 at 01:15, 1 year 10 months ago

Biophytis prolonge son contrat avec Atlas pour financer ses activités cliniques

Biophytis Biotechnologie Financement Obligations Convertibles Atlas
BRIEF

published on 06/20/2024 at 01:15, 1 year 10 months ago

Biophytis extends its contract with Atlas to finance its clinical activities

Biophytis Biotechnology Convertible Bonds Funding Atlas
PRESS RELEASE

published on 06/20/2024 at 01:10, 1 year 10 months ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités. Renouvellement de l'accord de financement obligataire pour le lancement de programmes cliniques OBA et MYODA

Contrat Biophytis Financement Atlas OBA
PRESS RELEASE

published on 06/20/2024 at 01:10, 1 year 10 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends financing agreement with Atlas, ensures funding for clinical programs OBA in obesity and MYODA in DMD. Details on the contract amendment and risk factors

Biophytis Atlas Financing Agreement Clinical Programs Risk Factors
BRIEF

published on 06/19/2024 at 23:05, 1 year 10 months ago

Biophytis prolonge son contrat avec Atlas pour le financement de ses activités

Biophytis Biotechnologie Financement ORNANE Atlas
BRIEF

published on 06/19/2024 at 23:05, 1 year 10 months ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 1 year 10 months ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis renouvelle son accord de financement avec Atlas pour sécuriser ses activités. La société émettra des obligations convertibles pour un montant maximum de 16 millions d'euros

Biophytis Financement Obligations Convertibles Atlas Programmes Cliniques
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 1 year 10 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends bond financing agreement with Atlas, securing funding for clinical programs in obesity and Duchenne Muscular Dystrophy. Terms reflect confidence in growth potential

Biophytis Atlas Growth Potential Clinical Programs Bond Financing Agreement
BRIEF

published on 06/12/2024 at 10:16, 1 year 10 months ago

Biophytis annonce le succès du transfert industriel de production de BIO101

Biophytis Biotechnologie Dystrophie Musculaire De Duchenne BIO101 Seqens
BRIEF

published on 06/12/2024 at 10:16, 1 year 10 months ago

Biophytis announces the success of the industrial transfer of production of BIO101

Biophytis Biotechnology Duchenne Muscular Dystrophy BIO101 Seqens

Accesswire

Published on 05/08/2026 at 01:50, 6 hours 38 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 7 hours 43 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 8 hours 28 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 8 hours 58 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 9 hours 13 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 08:02, 26 minutes ago

Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 08:00, 27 minutes ago

LIBERO to attend the World Football Summit in Madrid
Published on 05/08/2026 at 07:58, 30 minutes ago

Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 07:55, 33 minutes ago

AUSTRIAN POST IN Q1 2026: Slight first-quarter revenue improvement despite a challenging market environment, earnings below the previous year as expected
Published on 05/08/2026 at 07:30, 58 minutes ago

Bechtle achieves double-digit growth in business volume and earnings

Les Echos

Published on 05/07/2026 at 19:15, 13 hours 13 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 13 hours 13 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 13 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 13 hours 22 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 13 hours 28 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE